Podcast Episodes

Back to Search
152: Is an Indian CDMO the Right Move for Your Biologics Pipeline? with Abdelaziz Toumi - Part 2

Episode 152

Is an Indian CDMO the right move for your biologics CMC development?

Pulling back the curtain on what might be your next strategic manufacturing advan…

1 year, 1 month ago

Short Long
View Episode
151: Is an Indian CDMO the Right Move for Your Biologics Pipeline? with Abdelaziz Toumi - Part 1

Episode 151

Is an Indian CDMO the right move for your biologics pipeline?

As Western biotech companies seek new strategic advantages, one question keeps surfacing…

1 year, 1 month ago

Short Long
View Episode
150: How to Leverage AI in Media Development Without Sacrificing Process Understanding with Tom Fletcher - Part 2

Episode 150

As biotech labs rush to adopt AI tools for cell culture media development, a critical question emerges: Are we creating a generation of scientists wh…

1 year, 1 month ago

Short Long
View Episode
149: How to Leverage AI in Media Development Without Sacrificing Process Understanding with Tom Fletcher - Part 1

Episode 149

From closely-guarded secrets to complex chemical interactions, cell culture media development has transformed from an afterthought to a critical comp…

1 year, 1 month ago

Short Long
View Episode
148: Lab-Grown Blood: How Stem Cells Transform Transfusions with Ari Gargir - Part 2

Episode 148

In the wake of the COVID-19 pandemic, the fragility of global blood supply systems became undeniably clear. Recognizing the urgent need for a more re…

1 year, 1 month ago

Short Long
View Episode
147: Lab-Grown Blood: How Stem Cells Transform Transfusions with Ari Gargir - Part 1

Episode 147

Blood is critical to global healthcare - vital for surgeries, trauma care, cancer treatment, and maternal health. Yet despite 120 million donations e…

1 year, 1 month ago

Short Long
View Episode
146: Beyond ELISA: The 10-Minute Immunoassay Enabling Real-Time Bioprocess Control with Bruno Oesch - Part 2

Episode 146

Stuck with outdated analytics while trying to develop cutting-edge therapies? Part 2 of our conversation with Bruno Oesch, CEO and founder of Elionov…

1 year, 2 months ago

Short Long
View Episode
145: Beyond ELISA: The 10-Minute Immunoassay Enabling Real-Time Bioprocess Control with Bruno Oesch - Part 1

Episode 145

Tired of waiting overnight for ELISA results? Serial entrepreneur Bruno Oesch reveals how his groundbreaking 10-minute immunoassay technology is elim…

1 year, 2 months ago

Short Long
View Episode
144: The Future of Biotech: Making Biotherapeutics More Accessible Faster

Episode 144

Imagine a future where every patient can access life-saving therapies and sustainable, high-quality food is within everyone’s reach. In this episode …

1 year, 2 months ago

Short Long
View Episode
143: Bioprocess Breakthroughs: How Smart Bioprocessing Is Democratizing Life-Saving Treatments

Episode 143

In the rapidly evolving world of biotechnology, innovation is not just happening at the molecular level. Industry leaders are making groundbreaking a…

1 year, 2 months ago

Short Long
View Episode

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us